Amyloid-β: a potential link between epilepsy and cognitive decline

M Romoli, A Sen, L Parnetti, P Calabresi… - Nature Reviews …, 2021 - nature.com
People with epilepsy—in particular, late-onset epilepsy of unknown aetiology—have an
elevated risk of dementia, and seizures have been detected in the early stages of Alzheimer …

Neuropsychiatric and cognitive comorbidities in epilepsy

M Mula, H Coleman, SJ Wilson - CONTINUUM: Lifelong Learning …, 2022 - journals.lww.com
Neuropsychiatric and Cognitive Comorbidities in Epilepsy : CONTINUUM: Lifelong
Learning in Neurology Account Register Activate Subscription Help Subscribe American …

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

O Devinsky, E Marsh, D Friedman, E Thiele… - The Lancet …, 2016 - thelancet.com
Background Almost a third of patients with epilepsy have a treatment-resistant form, which is
associated with severe morbidity and increased mortality. Cannabis-based treatments for …

[HTML][HTML] Cannabinoid treatment for autism: a proof-of-concept randomized trial

A Aran, M Harel, H Cassuto, L Polyansky, A Schnapp… - Molecular autism, 2021 - Springer
Background Endocannabinoid dysfunction in animal models of autism spectrum disorder
(ASD) and accumulating, albeit anecdotal, evidence for efficacy in humans motivated this …

Rapid detection of generalized anxiety disorder and major depression in epilepsy: validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample

JA Micoulaud-Franchi, S Lagarde, G Barkate… - Epilepsy & Behavior, 2016 - Elsevier
Objective Generalized anxiety disorder (GAD) in people with epilepsy (PWE) is
underdiagnosed and undertreated. The GAD-7 is a screening questionnaire to detect GAD …

Determinants of health‐related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated …

C Luoni, F Bisulli, MP Canevini, G De Sarro… - …, 2011 - Wiley Online Library
Purpose: To evaluate the relative contribution of demographic and epilepsy‐related
variables, depressive symptoms, and adverse effects (AEs) of antiepileptic drugs (AEDs) to …

[HTML][HTML] Determinants of quality of life in adults with epilepsy: a multicenter, cross-sectional study from Germany

K Siebenbrodt, LM Willems, F von Podewils… - … Research and Practice, 2023 - Springer
Background Assessment of quality of life (QoL) has become an important indicator for
chronic neurological diseases. While these conditions often limit personal independence …

Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug‐refractory …

MP Canevini, G De Sarro, CA Galimberti, G Gatti… - …, 2010 - Wiley Online Library
Purpose: To evaluate the adverse effects (AEs) of antiepileptic drugs (AEDs) in adults with
refractory epilepsy and their relationship with number of coprescribed AEDs and AED load …

Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients

S Petrovski, CEI Szoeke, NC Jones, MR Salzberg… - Neurology, 2010 - AAN Enterprises
Objectives: To test the hypothesis that neuropsychiatric symptomatology is predictive of the
success of seizure control in patients newly treated with antiepileptic drugs (AEDs), and that …

Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

L Cardamone, MR Salzberg, TJ O'brien… - British journal of …, 2013 - Wiley Online Library
There is a high incidence of psychiatric comorbidity in people with epilepsy (PWE),
particularly depression. The manifold adverse consequences of comorbid depression have …